T1	GGPs 1970 1974	CTGF
T3	Pharmacological_substance 1943 1950	FG-3019
T5	Anatomical_entity 1603 1607	lung
T17	Disorder 180 188	fibrosis
T18	Artificial_process 527 553	intraperitoneal injections
T22	Pharmacological_substance 903 910	FG-3019
T24	GGPs 1008 1015	proline
T26	Pharmacological_substance 1541 1548	FG-3019
T28	Artificial_process 1134 1148	administration
T32	Artificial_process 1648 1657	treatment
T33	Subject 45 58	animal models
T34	Anatomical_entity 1072 1077	liver
T40	GGPs 557 561	CTGF
T42	GGPs 1809 1813	CTGF
T45	Pharmacological_substance 1401 1408	FG-3019
T46	Disorder 1740 1748	fibrosis
T47	Speculation_cue 135 149	widely thought
T49	Anatomical_entity 1863 1869	tissue
T52	Disorder 691 709	pulmonary fibrosis
T56	GGPs 27 31	CTGF
T64	Pharmacological_substance 1631 1647	FG-3019 antibody
T66	Pharmacological_substance 862 869	FG-3019
T74	GGPs 756 760	CTGF
T77	Disorder 1391 1399	fibrosis
T81	GGPs 126 130	CTGF
T82	Disorder 498 506	fibrosis
T83	Disorder 616 630	renal fibrosis
T84	Subject 837 842	human
T85	GGPs 380 384	CTGF
T86	Subject 1505 1512	animals
T89	Anatomical_entity 1426 1431	renal
T98	GGPs 993 1007	hydroxyproline
T104	GGPs 848 852	CTGF
T107	GGPs 853 861	antibody
T108	GGPs 1236 1240	CTGF
T110	Pharmacological_substance 1487 1496	bleomycin
T112	Anatomical_entity 388 394	tissue
T113	GGPs 1374 1378	CTGF
T119	Anatomical_entity 1043 1049	kidney
T120	GGPs 1159 1167	cytokine
T121	Anatomical_entity 1103 1107	lung
T126	GGPs 1689 1697	collagen
E3	Artificial_process:T18 Instrument:T40
E5	Artificial_process:T28 Instrument:T120
N3	Reference T1 UMLS:C0110610	connective tissue growth factor
N9	Reference T3 UMLS:C2985186	FG 3019
N22	Reference T5 UMLS:C0024109	Lung
N63	Reference T17 UMLS:C0016059	Fibrosis
N68	Reference E3 UMLS:C0021493	Injections, Intraperitoneal
N78	Reference T22 UMLS:C2985186	FG 3019
N84	Reference T24 UMLS:C0033382	Proline
N90	Reference T26 UMLS:C2985186	FG 3019
N151	Reference T40 UMLS:C0110610	connective tissue growth factor
N158	Reference T42 UMLS:C0110610	connective tissue growth factor
N168	Reference T45 UMLS:C2985186	FG 3019
N170	Reference T46 UMLS:C0016059	Fibrosis
N180	Reference T49 UMLS:C0040300	Body tissue
N192	Reference T52 UMLS:C0034069	Pulmonary Fibrosis
N206	Reference T56 UMLS:C0110610	connective tissue growth factor
N236	Reference T64 UMLS:C2985186	FG 3019
N245	Reference T66 UMLS:C2985186	FG 3019
N277	Reference T74 UMLS:C0110610	connective tissue growth factor
N284	Reference T77 UMLS:C0016059	Fibrosis
N296	Reference T81 UMLS:C0110610	connective tissue growth factor
N299	Reference T82 UMLS:C0016059	Fibrosis
N303	Reference T83 UMLS:C0151650	Renal fibrosis
N306	Reference T84 UMLS:C0086418	Homo sapiens
N309	Reference T85 UMLS:C0110610	connective tissue growth factor
N325	Reference T89 UMLS:C0022646	Kidney
N355	Reference T98 UMLS:C0020388	Hydroxyproline
N374	Reference T104 UMLS:C0110610	connective tissue growth factor
N390	Reference T107 UMLS:C0003241	Antibodies
N394	Reference T108 UMLS:C0110610	connective tissue growth factor
N402	Reference T110 UMLS:C0005740	Bleomycin
N408	Reference T112 UMLS:C0040300	Body tissue
N414	Reference T113 UMLS:C0110610	connective tissue growth factor
N433	Reference T119 UMLS:C0022646	Kidney
N439	Reference T120 UMLS:C0079189	cytokine
N443	Reference T121 UMLS:C0024109	Lung
N455	Reference T126 UMLS:C0009325	Collagen
T128	Biological_process 395 403	fibrosis
E12	Biological_process:T128 Theme:T112
N2	Reference E12 UMLS:C0016059	Fibrosis
T131	Biological_process 1287 1295	fibrosis
E15	Biological_process:T131 
N8	Reference E15 UMLS:C0016059	Fibrosis
T134	Biological_process 1870 1878	fibrosis
E18	Biological_process:T134 Theme:T49
N14	Reference E18 UMLS:C0016059	Fibrosis
T135	Pharmacological_substance 659 668	bleomycin
N16	Reference T135 UMLS:C0005740	Bleomycin
T6	GGPs 1017 1020	Hyp
N18	Reference T6 UMLS:C0020388	Hydroxyproline
T2	GGPs 36 41	TGF-β
N7	Reference T2 UMLS:C0040690	Transforming Growth Factor beta
T29	GGPs 211 245	transforming growth factor (TGF)-β
N19	Reference T29 UMLS:C0040690	Transforming Growth Factor beta
T58	GGPs 1315 1320	TGF-β
N21	Reference T58 UMLS:C0040690	Transforming Growth Factor beta
T105	GGPs 1818 1823	TGF-β
N23	Reference T105 UMLS:C0040690	Transforming Growth Factor beta
T19	GGPs 93 124	Connective tissue growth factor
N24	Reference T19 UMLS:C0110610	connective tissue growth factor
T8	Biological_process 793 810	fibrotic response
E19	Biological_process:T8 
N4	Reference E19 UMLS:C0596570	fibrogenesis
T44	Biological_process 1193 1210	fibrotic response
E20	Biological_process:T44 
N26	Reference E20 UMLS:C0596570	fibrogenesis
T100	GGPs 1432 1435	Hyp
T106	GGPs 1021 1024	Pro
N30	Reference T106 UMLS:C0033382	Proline
T114	GGPs 1436 1439	Pro
N33	Reference T114 UMLS:C0033382	Proline
T136	GGPs 1608 1611	Hyp
N34	Reference T136 UMLS:C0020388	Hydroxyproline
T21	GGPs 765 771	TGF-β2
N36	Reference T21 UMLS:C0079441	Transforming Growth Factor Beta 2
T59	GGPs 566 572	TGF-β2
N38	Reference T59 UMLS:C0079441	Transforming Growth Factor Beta 2
N27	Reference T100 UMLS:C0020388	Hydroxyproline
N41	Reference T33 UMLS:C0599779	Animal Model
T55	Subject 435 448	murine models
N45	Reference T55 UMLS:C2986594	Mouse Model
R1	Subject_Disorder Arg1:T55 Arg2:T71	
T43	Disorder 62 78	fibrotic disease
N35	Reference T43 UMLS:C0016059	Fibrosis
T71	Disorder 452 468	fibrotic disease
N48	Reference T71 UMLS:C0016059	Fibrosis
T80	Disorder 1287 1295	fibrosis
N50	Reference T80 UMLS:C0016059	Fibrosis
T13	Disorder 578 630	unilateral ureteral obstruction (UUO) renal fibrosis
R2	member_of Arg1:T13 Arg2:T83	
N47	Reference T34 UMLS:C0023884	Liver
T75	Negative_regulation 1671 1678	reduced
E22	Negative_regulation:T75 Theme:E41 Cause:E14
N56	Reference E22 UMLS:C3463820	Inhibition
T76	Positive_regulation 507 514	induced
E23	Positive_regulation:T76 Cause:E3 Theme:T82
N57	Reference E23 UMLS:C1879547	Activation action
T93	Negative_regulation 820 829	inhibited
E24	Negative_regulation:T93 Theme:E19 Cause:T66
N58	Reference E24 UMLS:C3463820	Inhibition
T116	Positive_regulation 153 160	promote
E27	Positive_regulation:T116 Theme:E37 Cause:T19 Cue:T47
N62	Reference E27 UMLS:C1879547	Activation action
T102	Positive_regulation 772 780	elicited
E28	Positive_regulation:T102 Cause:E39 Theme:E19
N64	Reference E28 UMLS:C1879547	Activation action
T117	Positive_regulation 1184 1190	elicit
E29	Positive_regulation:T117 Cue:T27 Cause:E5 Theme:E20
N65	Reference E29 UMLS:C1879547	Activation action
T123	Positive_regulation 1850 1856	elicit
E30	Positive_regulation:T123 Theme:E18
N66	Reference E30 UMLS:C1879547	Activation action
T103	Negative_regulation 914 924	ameliorate
E31	Negative_regulation:T103 Cause:T22 Theme:T30
N67	Reference E31 UMLS:C3463820	Inhibition
T118	Positive_regulation 1278 1286	initiate
E32	Positive_regulation:T118 Cause:T108 Theme:E15 Cue:T14
N69	Reference E32 UMLS:C1879547	Activation action
T78	Positive_regulation 1838 1846	required
E33	Positive_regulation:T78 Cause:E7 Theme:E30
N70	Reference E33 UMLS:C1879547	Activation action
T137	Pathway 1809 1813;1824 1833	CTGF signaling
E35	Pathway:T137 Participant:T42
N72	Reference E35 UMLS:C0037080	Signal Pathways
T138	Biological_process 165 176	development
E37	Biological_process:T138 Theme:T17
N75	Reference E37 UMLS:C0699748	Pathogenesis
T88	Biological_process 1497 1504	injured
E38	Biological_process:T88 Theme:T86 Cause:T110
N76	Reference E38 UMLS:C0010957	Tissue damage
N83	Reference E5 UMLS:C1621583	Administer
T141	Localization 1698 1708	deposition
E41	Localization:T141 Theme:T126
N85	Reference E41 UMLS:C4055506	Accumulation
T143	Regulation 1932 1939	effects
E43	Regulation:T143 Cause:T3 Theme:E16 Cue:T95
N49	Reference E43 UMLS:C1327622	Regulation of biological process
T70	Artificial_process 645 658;669 681	intratracheal instillation
E9	Artificial_process:T70 Instrument:T135
N79	Reference E9 UMLS:C1555389	Instillation, intratracheal
T139	Artificial_process 720 752	Intraperitoneal coadministration
E39	Artificial_process:T139 Instrument:T74 Instrument2:T21
N87	Reference E39 UMLS:C0021493	Injections, Intraperitoneal
T7	Pathway 1818 1833	TGF-β signaling
E4	Pathway:T7 Participant:T105
T35	Molecular_function 1788 1800	interactions
E7	Molecular_function:T35 Participant:E35 Participant2:E4
N32	Reference E7 UMLS:C1148560	molecular_function
T39	Molecular_function 12 23	interaction
E8	Molecular_function:T39 Theme:T56 Theme2:T2
N51	Reference E8 UMLS:C1148560	molecular_function
N44	Reference T86 UMLS:C0003062	Animals
R3	Subject_Disorder Arg1:T33 Arg2:T43	
T63	Artificial_process 527 553	intraperitoneal injections
E11	Artificial_process:T63 Instrument:T59
N5	Reference E11 UMLS:C0021493	Injections, Intraperitoneal
T67	Positive_regulation 507 514	induced
E13	Positive_regulation:T67 Cause:E11 Theme:T82
N46	Reference E13 UMLS:C1879547	Activation action
T30	Disorder 949 957	fibrosis
N25	Reference T30 UMLS:C0016059	Fibrosis
T27	Negation_cue 1174 1183	failed to
A1	Negated E29
T36	Negative_regulation 1584 1593	reduction
E2	Negative_regulation:T36 Theme:T136 Cause:T26
N55	Reference E2 UMLS:C3463820	Inhibition
E10	Negative_regulation:T75 Cause:E14 Theme:E1
N53	Reference E10 UMLS:C3463820	Inhibition
E14	Artificial_process:T32 Instrument:T64
N71	Reference E14 UMLS:C1621583	Administer
T15	Disorder 2037 2063	fibroproliferative disease
N12	Reference T15 UMLS:C0016059	Fibrosis
T14	Speculation_cue 1217 1230	demonstrating
A2	Speculated E32
R4	part_of Arg1:T5 Arg2:T86	
T51	Biological_process 1740 1748	fibrosis
E1	Biological_process:T51 
N10	Reference E1 UMLS:C0016059	Fibrosis
T60	Artificial_process 1975 1982	therapy
E6	Artificial_process:T60 
N54	Reference E6 UMLS:C0087111	Therapeutic procedure
T50	Negative_regulation 1918 1922	anti
E16	Negative_regulation:T50 Theme:E17
N74	Reference E16 UMLS:C3463820	Inhibition
T115	Biological_process 1923 1931	fibrotic
E17	Biological_process:T115 
N77	Reference E17 UMLS:C0596570	fibrogenesis
T95	Speculation_cue 1909 1917	observed
A3	Speculated E43
T124	GGPs 843 861	anti-CTGF antibody
R5	member_of Arg1:T124 Arg2:T107	
N82	Reference E4 UMLS:C1515163	TGF Beta Signaling Pathway BioCarta
